Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 89 items for :

  • palliative care x
  • Refine by access: All content x
Clear All
Jaydira Del Rivero Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA

Search for other papers by Jaydira Del Rivero in
Google Scholar
PubMed Close
,
Josh Mailman NorCal CarciNET Community, Oakland, California, USA

Search for other papers by Josh Mailman in
Google Scholar
PubMed Close
,
Michael W Rabow Department of Internal Medicine, Division of Palliative Medicine, University of California, San Francisco, San Francisco, California, USA

Search for other papers by Michael W Rabow in
Google Scholar
PubMed Close
,
Jennifer A Chan Harvard Medical School, Program in Carcinoid and Neuroendocrine Tumors, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Jennifer A Chan in
Google Scholar
PubMed Close
,
Sarah Creed Good Shepherd Community Care, Harvard Kennedy School, Natick, Massachusetts, USA

Search for other papers by Sarah Creed in
Google Scholar
PubMed Close
,
Hagen F Kennecke Providence Cancer Institute Franz Clinic, Portland Providence Medical Center, Portland, Oregon, USA

Search for other papers by Hagen F Kennecke in
Google Scholar
PubMed Close
,
Janice Pasieka Department of Surgery, Section of General Surgery, University of Calgary, Cumming School of Medicine, Calgary, Canada

Search for other papers by Janice Pasieka in
Google Scholar
PubMed Close
,
Jennifer Zuar Department of Internal Medicine, Division of Geriatrics and Palliative Medicine, Alpert Medical School, Providence, Rhode Island, USA

Search for other papers by Jennifer Zuar in
Google Scholar
PubMed Close
,
Simron Singh Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Search for other papers by Simron Singh in
Google Scholar
PubMed Close
, and
Lauren Fishbein Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA

Search for other papers by Lauren Fishbein in
Google Scholar
PubMed Close

How do we define palliative care, and when should it be started? Palliative care is a medical subspecialty that focuses on alleviating the symptoms and stress associated with serious medical illness. Palliative care is appropriate for any

Article Type:
Other
DOI:
https://doi.org/10.1530/ERC-22-0226
Volume/Issue:
Volume 30: Issue 7
Open access
B Wängberg Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by B Wängberg in
Google Scholar
PubMed Close
,
A Khorram-Manesh Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by A Khorram-Manesh in
Google Scholar
PubMed Close
,
S Jansson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by S Jansson in
Google Scholar
PubMed Close
,
B Nilsson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by B Nilsson in
Google Scholar
PubMed Close
,
O Nilsson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by O Nilsson in
Google Scholar
PubMed Close
,
C E Jakobsson Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by C E Jakobsson in
Google Scholar
PubMed Close
,
S Lindstedt Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by S Lindstedt in
Google Scholar
PubMed Close
,
A Odén Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by A Odén in
Google Scholar
PubMed Close
, and
H Ahlman Surgery, Clinical Chemistry, Department of Mathemathical Sciences, Departments of

Search for other papers by H Ahlman in
Google Scholar
PubMed Close

and cisplatin (EDP-regimen) versus streptozotocin is currently under investigation for palliative purposes in the FIRM-ACT study ( http://www.firm-act.org ). The prognosis in ACC relates to tumour stage ( Icard et al . 2001 , Abiven et al

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-09-0190
Volume/Issue:
Volume 17: Issue 1
Free access
Jack Junjie Chan Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore

Search for other papers by Jack Junjie Chan in
Google Scholar
PubMed Close
,
Yirong Sim Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore

Search for other papers by Yirong Sim in
Google Scholar
PubMed Close
,
Samuel Guan Wei Ow Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Search for other papers by Samuel Guan Wei Ow in
Google Scholar
PubMed Close
,
Joline Si Jing Lim Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Search for other papers by Joline Si Jing Lim in
Google Scholar
PubMed Close
,
Grace Kusumawidjaja Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Grace Kusumawidjaja in
Google Scholar
PubMed Close
,
Qingyuan Zhuang Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Qingyuan Zhuang in
Google Scholar
PubMed Close
,
Ru Xin Wong Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Ru Xin Wong in
Google Scholar
PubMed Close
,
Fuh Yong Wong Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore

Search for other papers by Fuh Yong Wong in
Google Scholar
PubMed Close
,
Veronique Kiak Mien Tan Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
Division of Surgery & Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
SingHealth Duke-NUS Breast Centre, Singapore General Hospital, Singapore, Singapore

Search for other papers by Veronique Kiak Mien Tan in
Google Scholar
PubMed Close
, and
Tira Jing Ying Tan Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore

Search for other papers by Tira Jing Ying Tan in
Google Scholar
PubMed Close

. Cancer care services During the ‘circuit breaker’ period in Singapore, hospital-based cancer care services, inpatient hospices and home palliative care are considered as essential and remain operational. Otherwise, cancer screening and surveillance

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0157
Volume/Issue:
Volume 27: Issue 9
Free access
J Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by J Crona in
Google Scholar
PubMed Close
,
F Beuschlein Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich, Zürich, Switzerland

Search for other papers by F Beuschlein in
Google Scholar
PubMed Close
,
K Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by K Pacak in
Google Scholar
PubMed Close
, and
B Skogseid Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by B Skogseid in
Google Scholar
PubMed Close

Study design Setting Recruitment target, n patients NCT number Randomized studies  Sunitinib Phase II, placebo controlled Palliative 74 Nbib1371201  Phenoxybenzamine vs doxazosin Phase III Curative and palliative

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-18-0138
Volume/Issue:
Volume 25: Issue 7
Open access
Anela Blazevic Department of Internal Medicine, section Endocrinology, Erasmus MC, Rotterdam,

Search for other papers by Anela Blazevic in
Google Scholar
PubMed Close
,
Martijn P A Starmans Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands

Search for other papers by Martijn P A Starmans in
Google Scholar
PubMed Close
,
Tessa Brabander Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands

Search for other papers by Tessa Brabander in
Google Scholar
PubMed Close
,
Roy S Dwarkasing Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands

Search for other papers by Roy S Dwarkasing in
Google Scholar
PubMed Close
,
Renza A H van Gils Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands

Search for other papers by Renza A H van Gils in
Google Scholar
PubMed Close
,
Johannes Hofland Department of Internal Medicine, section Endocrinology, Erasmus MC, Rotterdam,

Search for other papers by Johannes Hofland in
Google Scholar
PubMed Close
,
Gaston J H Franssen Department of Surgery, Erasmus MC, Rotterdam, the Netherlands

Search for other papers by Gaston J H Franssen in
Google Scholar
PubMed Close
,
Richard A Feelders Department of Internal Medicine, section Endocrinology, Erasmus MC, Rotterdam,

Search for other papers by Richard A Feelders in
Google Scholar
PubMed Close
,
Wiro J Niessen Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
Faculty of Applied Sciences, Department of Radiology and Nuclear Medicine, Delft University of Technology, Delft, the Netherlands

Search for other papers by Wiro J Niessen in
Google Scholar
PubMed Close
,
Stefan Klein Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands

Search for other papers by Stefan Klein in
Google Scholar
PubMed Close
, and
Wouter W de Herder Department of Internal Medicine, section Endocrinology, Erasmus MC, Rotterdam,

Search for other papers by Wouter W de Herder in
Google Scholar
PubMed Close

symptoms ( Blazevic et al. 2018 b , Daskalakis et al. 2018 ). In addition, recent studies found no survival or clinical benefit of prophylactic palliative surgery in asymptomatic patients (Blažević et al. 2018 a , Daskalakis et al. 2018

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-21-0064
Volume/Issue:
Volume 28: Issue 8
Restricted access
Katherine I Wolf Department of Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA

Search for other papers by Katherine I Wolf in
Google Scholar
PubMed Close
,
Linda Rose-Krasnor Pheo Para Alliance and Psychology Department, Brock University, St. Catharines, Ontario, Canada

Search for other papers by Linda Rose-Krasnor in
Google Scholar
PubMed Close
,
Stephanie Alband Pheo Para Alliance, Alexandria, Virginia, USA

Search for other papers by Stephanie Alband in
Google Scholar
PubMed Close
,
Jacques W M Lenders Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands

Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed Close
, and
Lauren Fishbein Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, and Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA

Search for other papers by Lauren Fishbein in
Google Scholar
PubMed Close

$2500 for health insurance, 13 had an annual cost of over $10,000/year. Figure 3 Personal financial burden related to pheochromocytoma/paraganglioma diagnosis and treatment. *Clinical nurse care, emergency medicine services, palliative care

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0349
Volume/Issue:
Volume 31: Issue 6
Restricted access
L D de Hosson Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by L D de Hosson in
Google Scholar
PubMed Close
,
J Stelwagen Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by J Stelwagen in
Google Scholar
PubMed Close
,
G Bouma Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by G Bouma in
Google Scholar
PubMed Close
,
B Sijtema Dieticians, Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by B Sijtema in
Google Scholar
PubMed Close
,
S Huitema Dieticians, Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by S Huitema in
Google Scholar
PubMed Close
,
H J R van Faassen Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by H J R van Faassen in
Google Scholar
PubMed Close
,
G H de Bock Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by G H de Bock in
Google Scholar
PubMed Close
,
D J A de Groot Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by D J A de Groot in
Google Scholar
PubMed Close
,
M J E Campmans-Kuijpers Department of Gastroenterology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by M J E Campmans-Kuijpers in
Google Scholar
PubMed Close
,
I P Kema Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by I P Kema in
Google Scholar
PubMed Close
,
E G E de Vries Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by E G E de Vries in
Google Scholar
PubMed Close
, and
A M E Walenkamp Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by A M E Walenkamp in
Google Scholar
PubMed Close

first 4 weeks, standard care was continued. Thereafter, patients started with DIVIT. Dietician consultations were conducted at T4 by 1 out-patient visit and after 5, 10 and 15 weeks by telephone. Vitamin supplementation started at T4 or at week 8. The

Article Type:
Letter
DOI:
https://doi.org/10.1530/ERC-17-0549
Volume/Issue:
Volume 25: Issue 3
Free access
Alessandra Mangone Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK

Search for other papers by Alessandra Mangone in
Google Scholar
PubMed Close
,
Barbara Altieri Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Barbara Altieri in
Google Scholar
PubMed Close
,
Mario Detomas Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Mario Detomas in
Google Scholar
PubMed Close
,
Alessandro Prete Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Alessandro Prete in
Google Scholar
PubMed Close
,
Haider Abbas Oncology Department, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Haider Abbas in
Google Scholar
PubMed Close
,
Miriam Asia Department of Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Miriam Asia in
Google Scholar
PubMed Close
,
Yasir S Elhassan Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Yasir S Elhassan in
Google Scholar
PubMed Close
,
Giovanna Mantovani Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Search for other papers by Giovanna Mantovani in
Google Scholar
PubMed Close
, and
Cristina L Ronchi Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Cristina L Ronchi in
Google Scholar
PubMed Close

). Moreover, approximately half of the patients have metastatic or inoperable disease at diagnosis ( Shariq & McKenzie 2021 ). For patients with advanced ACC, mitotane represents the current standard of care, used as monotherapy for selected patients with low

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0372
Volume/Issue:
Volume 30: Issue 4
Open access
Derek Raghavan Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Derek Raghavan in
Google Scholar
PubMed Close
,
Antoinette R Tan Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Antoinette R Tan in
Google Scholar
PubMed Close
,
E Shannon Story Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by E Shannon Story in
Google Scholar
PubMed Close
,
Earle F Burgess Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Earle F Burgess in
Google Scholar
PubMed Close
,
Laura Musselwhite Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Laura Musselwhite in
Google Scholar
PubMed Close
,
Edward S Kim Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Edward S Kim in
Google Scholar
PubMed Close
, and
Peter E Clark Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA

Search for other papers by Peter E Clark in
Google Scholar
PubMed Close

especially emphasized. Frequent video or phone contact when office visits are reduced can be immensely reassuring and should be considered a vital part of the palliative strategy. Individualizing care for patients with rare and complex tumors is imperative

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0229
Volume/Issue:
Volume 27: Issue 9
Free access
V Craig Jordan Departments of Oncology and Pharmacology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20057, USA

Search for other papers by V Craig Jordan in
Google Scholar
PubMed Close

career path as treatments were primitive and invariably unsuccessful (except for childhood leukemia). Tamoxifen and I became the ‘odd couple’, but nobody cared in the 1970s, as combination cytotoxic chemotherapy was predicted to cure cancer. Be that as it

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-14-0092
Volume/Issue:
Volume 21: Issue 3
Free access